Other languages Geron Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.79 ^USD	+6.46%		+2.71%	+79.62%

Mar. 19	Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants	MT
Mar. 15	Sector Update: Health Care Stocks Ease Late Afternoon	MT

Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants	Mar. 19
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 15
Sector Update: Health Care Stocks Softer Friday Afternoon	Mar. 15
Sector Update: Health Care	Mar. 15
Top Midday Gainers	Mar. 15
Geron Shares Soar on Positive FDA Advisory Panel's Vote on Imetelstat for Blood Disorder	Mar. 15
Sector Update: Health Care Stocks Edge Higher Premarket Friday	Mar. 15
Sector Update: Health Care	Mar. 15
Investors Turn Cautious Ahead of Next Week's Fed Meeting, Stifling US Equity Futures Pre-Bell	Mar. 15
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Rate Cut Hopes Wane	Mar. 15
Top Premarket Gainers	Mar. 15
Geron Corporation Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS	Mar. 14
Geron's blood disorder drug gets FDA advisers' backing	Mar. 14
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 12
Sector Update: Health Care	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting; Shares Slump	Mar. 12
Geron's Imetelstat's Safety a Key Focus for FDA's Oncology Drugs Advisory Committee Meeting	Mar. 12
US FDA staff flags concerns about Geron's anemia treatment	Mar. 12
Geron's Q4 Net Loss Narrows, Revenue Declines	Feb. 28
Geron Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28

No results for this search